Early-stage biotechs often overbuild systems too soon. Alicia Collins explains why flexibility, simple processes, and realistic assumptions matter most.
- Clinical Trial Operations, Investigational Product Management, And The Foundation For Effective Risk Management
- Building Trust In Clinical Supply Digital Transformation
- Why Clinical Supply Teams Need To Understand CDISC
- The Hidden Cost Of Poor Data In Global Supply Chains
- The Hidden Cost Of Convenience: Single-Use Supply Chain Vulnerabilities And Clinical Trial Continuity
- Reshoring Pressure Meets Manufacturing Reality
- CDMO Live Europe 2026: Partnerships For An Uncertain World
- Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report
ON-DEMAND WEBINARS
Gain expert insights on the future of RTSM strategy and its evolution with the changing clinical supply and technology landscape in our webinar.
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
This webinar demystifies the term “agile,” from an operational perspective, while highlighting the speed and flexibility these systems offer to be able to support complex protocols that require accelerated changes.
This webinar presents the ultimate guide to scenario planning through modern technology as a way to inform clinical supply decisions.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1366016941 software]( "Rethinking RTSM Software: When Bigger Isn't Better")
Rethinking RTSM Software: When Bigger Isn't BetterDon’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
![GettyImages-1764818961 warehouse, storage, inventory]( "GxP Inventory Delivers Real-Time Visibility, Operational Efficiency")
GxP Inventory Delivers Real-Time Visibility, Operational EfficiencyModernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.
-
![gettyimages-946264212-170667a]( "Navigate Complex Ancillary Supply Sourcing Challenges")
Navigate Complex Ancillary Supply Sourcing ChallengesExplore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain.
-
![GettyImages- 1317948272 drug delivery]( "RTSM Manages Clinical IP Dispensation In Schizophrenia Study")
RTSM Manages Clinical IP Dispensation In Schizophrenia StudyChallenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.
-
![An Insider’s Guide To Interactive Response Technology (IRT) For Clinical Trials]( "What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution")
What To Look For In Your IRT/RTSM Solution For A Simpler Trial ExecutionWhich factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
![GettyImages-155372946-cold-chain-cryopreservation-logistics]( "Ensuring On-Time Release Of CAR-T Cell Treatment In Spain")
Ensuring On-Time Release Of CAR-T Cell Treatment In SpainDue to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
![gettyimages-871704288-170667a]( "The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies")
The Patient-Centric Clinical Supply Chain For Cell And Gene TherapiesThis article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
![GettyImages-1744064144-pencil-hand-automation-gears-ai]( "Automation Testing In RTSM Software: What Is It And What's The Impact")
Automation Testing In RTSM Software: What Is It And What's The ImpactMove beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
![check computer for vitals-GettyImages-1446748436]( "Finding The Optimal IRT/RTSM Design For Your Clinical Trial")
Finding The Optimal IRT/RTSM Design For Your Clinical TrialDetermine the best IRT/RTSM design for your trial through consideration of the user, data collection, and future-proofing.
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
